Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00186 |
| Species: | Homo sapiens |
| Position : | chr3:46453226-46459225 |
| Year: | 2025 |
| Title: | Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | prostate cancer |
| PMID: | 40082405 |
| MONDO: | MONDO:0008316 |
| Tissue: | prostate |
| Tissue Ontology ID: | UBERON:0002367 |
| Cell Type: | prostate cancer cell |
| Experiment Type: | integrated epigenomic analysis |
| High Throughput Method: | ATAC-seq; RNA-seq; ChIP-seq (H3K27ac, H3K4me1) |
| Low Throughput Method: | ChIP-qPCR; luciferase reporter assay; 3C-qPCR; RNA-FISH; ChIRP; RIP-qPCR; western blot |
| Target gene : | LTF |
| TF name : | NR |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|